Skip to content

Citius Pharmaceuticals, Inc.: filings

Every Citius Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 60 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q3 2026481330001213900-26-090185
10-Q2026-05-15fiscal Q2 2026461250001213900-26-057842
10-Q2026-02-13fiscal Q1 202646890001213900-26-015878
10-K2025-12-23fiscal FY 202544870001213900-25-125333
10-Q2025-08-12fiscal Q3 2025411200001213900-25-074997
10-Q2025-05-14fiscal Q2 2025401130001213900-25-043360
10-Q2025-02-14fiscal Q1 202539790001213900-25-014321
10-K2024-12-27fiscal FY 202441800001213900-24-113149
10-Q2024-08-12fiscal Q3 2024361070001213900-24-067732
10-Q2024-05-14fiscal Q2 202435990001213900-24-042920
10-Q2024-02-14fiscal Q1 202434720001213900-24-014096
10-K2023-12-29fiscal FY 202336730001213900-23-099889
10-Q2023-08-14fiscal Q3 2023351020001213900-23-067024
10-Q2023-05-12fiscal Q2 202335980001213900-23-039031
10-Q2023-02-10fiscal Q1 202335720001213900-23-010315
10-K2022-12-22fiscal FY 202241770001213900-22-082217
10-Q2022-08-11fiscal Q3 2022391080001213900-22-046897
10-Q2022-05-12fiscal Q2 202233880001213900-22-025975
10-Q2022-02-10fiscal Q1 202230610001213900-22-006429
10-K2021-12-15fiscal FY 202135710001213900-21-065464
10-Q2021-08-12fiscal Q3 202135990001213900-21-042071
10-Q2021-05-13fiscal Q2 202131860001213900-21-025920
10-Q2021-02-11fiscal Q1 202130630001213900-21-008453
10-K2020-12-16fiscal FY 202032620001213900-20-043004
10-Q2020-08-14fiscal Q3 202031860001213900-20-022331
10-Q2020-05-14fiscal Q2 202028780001213900-20-012286
10-Q2020-02-13fiscal Q1 202028570001213900-20-003577
10-K2019-12-16fiscal FY 201931760001213900-19-026259
10-Q2019-08-14fiscal Q3 201926790001213900-19-015793
10-Q2019-05-15fiscal Q2 201926760001213900-19-008833
10-Q2019-02-14fiscal Q1 201926530001213900-19-002563
10-K2018-12-11fiscal FY 201828730001213900-18-017214
10-Q2018-08-14fiscal Q3 201827750001213900-18-011072
10-Q2018-05-11fiscal Q2 201827730001213900-18-005952
10-Q2018-02-14fiscal Q1 201827570001213900-18-001880
10-K2017-12-13fiscal FY 201730760001213900-17-013191
10-Q2017-08-14fiscal Q3 201727730001477932-17-003946
10-Q2017-05-15fiscal Q2 201727700001477932-17-002308
10-Q2017-02-14fiscal Q1 201726520001477932-17-000773
10-K2016-12-23fiscal FY 201630710001477932-16-014315
10-Q2016-08-15fiscal Q3 201628720001477932-16-011894
10-Q2016-05-20fiscal Q2 201627690001477932-16-010490
10-Q2016-02-12fiscal Q1 201623460001477932-16-008554
10-K2015-12-14fiscal FY 201524620001477932-15-007617
10-Q2015-08-13fiscal Q3 201523610001477932-15-005025
10-Q2015-05-13fiscal Q2 201521590001477932-15-003063
10-Q2015-02-17fiscal Q1 201522460001477932-15-001225
10-Q2014-08-14fiscal Q3 201421660001185185-14-002170
10-Q2014-05-15fiscal Q2 201423840001185185-14-001283
10-Q2014-02-19fiscal Q1 201423670001185185-14-000368
10-K2014-02-06fiscal FY 201324650001185185-14-000261
10-Q2013-09-18fiscal Q3 201324870001185185-13-002069
10-Q2013-05-13fiscal Q2 201323830001185185-13-001079
10-Q2013-02-08fiscal Q1 201324670001185185-13-000267
10-K2013-01-15fiscal FY 201224630001185185-13-000090
10-Q2012-08-17fiscal Q3 201224840001185185-12-001857
10-Q2012-05-11fiscal Q2 201224830001185185-12-000973
10-Q2012-02-14fiscal Q1 201224620001185185-12-000229
10-K2012-01-13fiscal FY 201119450001185185-12-000067
10-Q2011-08-26fiscal Q3 201118420001019687-11-002825

Inspect the source

Entity
Citius Pharmaceuticals, Inc. / CIK 0001506251
Captured
2026-09-20T09:12:24.553Z
SEC response SHA-256
dab437b1abcb106ce657672edecf4aab637b5713b2c1870820e246433043b176

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001506251.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))